Anne Paakinaho - UEFConnect

Refine your search

Information Publications

Research groups

Real-world Evidence Team 01.08.2015 -

Keywords

Parkinson's disease pharmacoepidemiology pharmacy real-world data register-based research

Publications

9/9 items

Reumalääkkeiden ja inhaloitavien beeta-2-agonistien yhteys Parkinsonin taudin riskiin – valtakunnallinen rekisteritutkimus
Paakinaho, Anne. 2025. Dosis. 41: 134-150 B1 Non-refereed journal articles
The EU project Real4Reg: unlocking real-world data with AI
Peltner, Jonas; Becker, Cornelia; Wicherski, Julia; Wortberg, Silja; Aborageh, Mohamed; Costa, Inês; Ehrenstein, Vera; Fernandes, Joana; Heß, Steffen; Horváth-Puhó, Erzsébet; Korcinska Handest, Monika Roberta; Lentzen, Manuel; Maguire, Peggy; Meedom, Niels Henrik; Moore, Rebecca; Moore, Vanessa; Nagy, Dávid; McNamara, Hillary; Paakinaho, Anne; Pfeifer, Kerstin; Pylkkänen, Liisa; Rajamaki, Blair; Reviers, Evy; Röthlein, Christoph; Russek, Martin; Silva, Célia; De Valck, Dirk; Vo, Thuan; Bräuner, . 2025. Health research policy and systems. 23: . 27 A1 Journal article (refereed), original research
Disease-modifying antirheumatic drugs and inhaled β2-adrenoceptor agonists and risk of Parkinson’s disease: a nationwide register-based study
Paakinaho, Anne. 2024. Publications of the University of Eastern Finland. Dissertations in Health Sciences G5 Doctoral dissertation (article)
Statin use and the risk of Parkinson's disease in persons with diabetes: A nested case–control study
Honkamaa, Kim; Paakinaho, Anne; Tolppanen, Anna-Maija; Kettunen, Raimo; Hartikainen, Sirpa; Tiihonen, Miia. 2024. British journal of clinical pharmacology. 90: 1463-1470 A1 Journal article (refereed), original research
Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease
Pirttilä, Aki; Tiihonen, Miia; Paakinaho, Anne; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2023. Journal of the american medical directors association. 24: 1290-1296.e4 A1 Journal article (refereed), original research
β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
Paakinaho, Anne; Tiihonen, Miia; Koskela, Heikki; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2023. Clinical epidemiology. 15: 695-705 A1 Journal article (refereed), original research
Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease
Paakinaho, Anne; Koponen, Marjaana; Tiihonen, Miia; Kauppi, Markku; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2022. Neurology. 98: e1273-e1281 A1 Journal article (refereed), original research
Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study
Koponen, Marjaana; Paakinaho, Anne; Lin, Julian; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2022. Clinical epidemiology. 14: 1217-1227 A1 Journal article (refereed), original research
Incidence of muscle relaxant use in relation to diagnosis of Parkinson's disease
Paakinaho, Anne; Karttunen, Niina; Koponen, Marjaana; Taipale, Heidi; Tolppanen, Anna-Maija; Hartikainen, Sirpa; Tiihonen, Miia. 2020. International journal of clinical pharmacy